News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Conference News AHA 2021 Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded L.A. McKeown November 18, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders L.A. McKeown November 14, 2021
News Daily News HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19 Caitlin E. Cox October 13, 2021
News Conference News ESC 2021 GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water Shelley Wood August 27, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results Todd Neale July 06, 2021
News Conference News ACC 2021 Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients Caitlin E. Cox May 07, 2021
News Conference News ACC 2021 Poorer Neighborhoods Pose Risks for Black Patients After Acute MI L.A. McKeown May 05, 2021
News Conference News EHRA 2021 No Clear Explanation for Benefits of Early Rhythm Control in EAST-AFNET4 Todd Neale April 27, 2021
News Daily News Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials L.A. McKeown April 26, 2021
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Features Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine Shelley Wood December 10, 2020
News Conference News A-fib Screening Yields Promising Results, But Uncertainty Remains: mSToPS and VITAL-AF Todd Neale November 19, 2020
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020